PSA and Prostate Health
Prostate-specific antigen is one of the most commonly ordered tests in men over 50 — but also one of the most controversial, due to a high false-positive rate.
Number of studies
1
Safety
Moderate
Time to effects
Not applicable — PSA is a diagnostic test, not an intervention.
Who it's for
Table of contents
TL;DR
Prostate-specific antigen is one of the most commonly ordered tests in men over 50 — but also one of the most controversial, due to a high false-positive rate.
- →May help detect prostate cancer at an earlier, more treatable stage
- →A simple, widely available blood test
- →Combined with other parameters (digital rectal exam, trend over time) gives a fuller picture of risk
| Test type | A protein produced by the prostate gland, measured in blood serum |
|---|---|
| Level of evidence | Moderate — its screening utility is the subject of ongoing clinical debate |
| Target group | Men over 50 (over 45 with a family history) |
| Limitation | Low specificity — elevated PSA more often results from benign hyperplasia than cancer |
| Status | A screening test requiring an individual decision together with a doctor |
Understand
Overview
PSA (prostate-specific antigen) is a protein produced by prostate gland cells, whose elevated blood level can indicate prostate cancer, but just as often results from benign prostatic hyperplasia, inflammation, or recent sexual activity. This low specificity is the source of a decades-long medical debate about the merits of routine PSA screening in asymptomatic men.
A study by Thompson and colleagues, following men with low PSA, revealed that even at a seemingly safe result below the commonly used threshold, the rate of prostate cancer detected on biopsy was surprisingly high, showing that there is no single, universally safe cutoff. At the same time, elevated PSA leads to many unnecessary biopsies in men without cancer, which carries real risks from the procedure itself — which is why the decision to screen should be an individual conversation with a doctor, taking into account age, family history, and patient preferences.
Who might actually find this useful? Men over 50 (or over 45 with a family history of prostate cancer) considering screening in consultation with a doctor. It's worth approaching the result with a full understanding of its limitations, rather than treating a single elevated reading as definitive proof of cancer.
Mechanism of action
PSA is a proteolytic enzyme physiologically produced by prostate gland epithelial cells, whose role is to liquefy semen. A small amount naturally enters the bloodstream, but disruption of the prostate tissue's normal architecture — whether by cancer, benign hyperplasia, or inflammation — increases PSA leakage into the blood, raising the concentration measured in the test.
Because both benign prostatic hyperplasia and prostate cancer can raise PSA into an overlapping range of values, PSA concentration alone doesn't allow these causes to be clearly distinguished — additional parameters, such as PSA velocity over time, the free-to-total PSA ratio, or a digital rectal exam, help the doctor assess the likelihood of cancer and decide on further diagnostics.
Physiological production by the prostate
PSA is naturally produced by prostate gland epithelial cells to liquefy semen.
Leakage into the bloodstream
Disruption of the prostate tissue's architecture increases PSA leakage into the blood.
Overlapping causes of elevation
Cancer, benign hyperplasia, and inflammation can all raise PSA into an overlapping range of values.
Evidence: moderate — based on 1 study in this database.
Benefits
Common myths
MythElevated PSA always means prostate cancer.
FactA far more common cause of elevated PSA is benign prostatic hyperplasia or inflammation — an elevated result calls for further diagnostics, not an automatic cancer diagnosis.
MythLow PSA completely rules out prostate cancer.
FactStudies show that even at a result below the commonly used cutoff, some men still had prostate cancer detected on biopsy — there is no single, fully safe threshold.
Check your profile
Not sure which supplements actually make sense for you?
Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Practice
Frequently asked questions
It's usually recommended to discuss the merits of the test with a doctor starting at age 50, or from age 45 with a family history of prostate cancer.
A doctor will usually recommend repeating the test, assessing additional parameters (free-to-total PSA ratio, digital rectal exam), and, if needed, further imaging or a biopsy.
Regular physical activity, a healthy diet, and maintaining a healthy body weight are associated in observational studies with lower risk of prostate problems, though they don't replace regular check-ups.
Safety
Side effects & contraindications
Possible side effects
Contraindications
No significant contraindications at typical doses.
Interactions
Recent sexual activity, cycling, or a digital rectal exam can temporarily raise the PSA result
Is it worth taking?
Who it's for
- Men over 50 considering screening in consultation with a doctor
- Men over 45 with a family history of prostate cancer
Not for
- No significant contraindications at typical doses.
Evidence
Worth knowing
The decision to perform routine PSA screening in asymptomatic men has been the subject of a decades-long debate in the medical community.
PSA velocity over time can be just as clinically significant as a single result on its own.
Studies
Even at a PSA concentration below the commonly used cutoff, the rate of prostate cancer detected on biopsy remains significant, underscoring the lack of a single, fully safe threshold for this test.
Thompson IM, et al., New England Journal of Medicine, 2004
Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter
Moderate evidenceThompson IM, Pauler DK, Goodman PJ, et al. · New England Journal of Medicine · 2004
A study showing a significant rate of prostate cancer detected on biopsy even in men with PSA below the commonly used cutoff.
View studySources & bibliography
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
dr Piotr ZielińskiEndocrinologist
Piotr has practiced endocrinology for more than fifteen years, mostly in male hormonal disorders and metabolic health. He joined VitMode as a scientific consultant because, as he jokes, he got tired of explaining the same testosterone questions at every appointment and decided to write the answers down properly, once. He reviews content on hormone therapy, supplement pharmacology and drug interactions, making sure articles never turn into encouragement to self-supplement in situations that genuinely need diagnostics and medical supervision. His professional motto — "evidence first, enthusiasm second" — has come up more than once with a patient who arrived with a supplement plan they found online.
268 publications on this site
Medical review
Michał NowakClinical Dietitian
Michał started out as a long-distance runner, before an injury forced him to rethink his career. Looking for a faster way back into shape, he discovered sports nutrition and never left — fascinated by the gap between the research and what "everyone knows" at the gym. He completed a degree in clinical dietetics, earned a sports-nutrition coaching certification, and ran his own practice for several years before joining VitMode. His writing keeps returning to one theme: a supplement won't replace the basics, but the right one, at the right time, makes a real difference — and that's the difference he tries to describe precisely, with citations instead of slogans. He still runs, though these days, as he puts it, purely for the fun of it.
154 publications on this site
Related entries
4.7Testosterone
The primary anabolic hormone — its natural level depends heavily on sleep, resistance training, body composition and fat mass.
4.5Andropause
A gradual decline in testosterone in middle-aged and older men, far milder than menopause — a real physiological phenomenon, but one that requires intervention less often than the popular understanding of the term suggests.
4.4Zinc
A trace element essential for the work of over 300 enzymes in the body — its deficiency, more common than widely believed, affects immunity, wound healing, and hormone balance.
4.7TRT and the Prostate: What PSA Results to Watch During Therapy
This isn't about whether TRT "causes" prostate cancer — the evidence doesn't point that way. It's about the specific protocol: when to check PSA before starting, when to recheck it after therapy begins, and exactly how much of a rise means it's time to see a urologist.
4.6Lipid Panel
The lipid panel is one of the most important — and still one of the most frequently misread — preventive blood tests: 'total cholesterol' alone tells you less than the ratios between its fractions.
4.6Benign Prostatic Hyperplasia (BPH)
A non-cancerous enlargement of the prostate gland affecting up to one in four men over a lifetime — and one of the few urological conditions where a large randomized trial showed a drug can cut the risk of acute urinary retention by more than half.
4.5How to Read a Basic Blood Test Panel
CBC, lipid panel, glucose, TSH — how to read the results of a basic blood panel so you catch early signals of a problem before it becomes a disease.
4.4Statins
The best-researched class of LDL-cholesterol-lowering drugs, with one of the largest evidence bases in all of cardiology — yet still surrounded by numerous, largely unfounded fears.
Related articles
Badania naukoweTRT and the Prostate: Does Testosterone Increase Prostate Cancer Risk?
For eighty years, medicine believed testosterone 'fed' prostate cancer, and that any rise in it was dangerous. Newer evidence forces a major narrowing of that rule — but not in the same way for every man.
August 15, 2026
PoradnikiSaw Palmetto for an Enlarged Prostate: What 4,656 Men in 27 Trials Actually Showed
Saw palmetto (Serenoa repens) is one of the best-selling herbal supplements in the world, marketed as natural support for men with benign prostatic enlargement and its urinary symptoms. A 2024 updated Cochrane review — pooling 27 trials and more than 4,600 men — found that, on its own, it moves the standard symptom score by less than one point versus placebo. The result is clear and worth discussing honestly: high-certainty evidence shows that saw palmetto alone provides little or no real benefit for symptom relief.
August 26, 2026
Poradniki5 Biomarkers Worth Knowing Before 40 — Signals Before Symptoms Appear
A standard "once-a-year blood count" often misses early signs of metabolic and hormonal issues. Here are five markers worth asking your doctor about, before anything starts to hurt.
August 1, 2026
PoradnikiMelatonin and Migraine in Children: Can a Supplement Replace Preventive Medication?
Migraine in children can seriously disrupt school, sleep, and daily life, and parents looking for a gentler alternative to prescription drugs increasingly come across melatonin as a preventive option. A carefully designed, randomized, placebo-controlled trial from the University of California, San Francisco, however, tells a much less clear-cut story than popular articles suggesting a ready-made solution.
September 2, 2026
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.